Reports for NOVARTIS PHARMACEUTICALS CANADA INC
Company Name
NOVARTIS PHARMACEUTICALS CANADA INC
Totals |
||
Shortage reports |
152 |
|
Actual shortage: | 5 (3%) | |
Anticipated shortage: | 1 (1%) | |
Avoided shortage: | 5 (3%) | |
Resolved: | 141 (93%) | |
Discontinuation Reports |
51 |
|
To be discontinued: | 0 (0%) | |
Discontinued: | 51 (100%) | |
Reversed: | 0 (0%) | |
Late reports |
34 (17%) |
|
Overdue reports |
1 (17%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
MAXIDEX | 0.1% | OINTMENT | Resolved | 2017-07-27 | 2017-09-08 | 17417 |
MAXIDEX | 0.1% | OINTMENT | Resolved | 2018-01-09 | 2018-01-19 | 35401 |
MAXIDEX | 0.1% | OINTMENT | Resolved | 2018-08-28 | 2019-02-05 | 59391 |
TOBREX | 3MG | OINTMENT | Resolved | 2018-01-08 | 2018-01-30 | 35259 |
TOBREX | 3MG | OINTMENT | Resolved | 2019-01-08 | 2019-01-28 | 71609 |
TOBREX | 3MG | OINTMENT | Resolved | 2019-02-11 | 2019-03-09 | 75340 |
TOBREX | 3MG | OINTMENT | Resolved | 2019-03-11 | 2019-04-06 | 78252 |
TOBREX | 3MG | OINTMENT | Resolved | 2019-04-08 | 2019-04-26 | 80771 |
TOBREX | 3MG | OINTMENT | Resolved | 2019-06-21 | 2019-09-06 | 87200 |
TOBREX | 0.3% | OINTMENT | Resolved | 2020-09-08 | 2021-02-24 | 123888 |
DESFERAL 500MG | 500MG | POWDER FOR SOLUTION | Resolved | 2023-04-28 | 2023-10-04 | 191074 |
DESFERAL 500MG | 500MG | POWDER FOR SOLUTION | Actual shortage | 2024-03-21 | 2024-05-07 | 222962 |
XOLAIR | 150MG | POWDER FOR SOLUTION | Resolved | 2023-11-22 | 2024-04-10 | 211221 |
XOLAIR | 150MG | POWDER FOR SOLUTION | Avoided shortage | 2024-04-10 | 2024-06-03 | 224781 |
EXTAVIA | 0.3MG | POWDER FOR SOLUTION | Resolved | 2019-12-03 | 2020-03-09 | 100125 |
VOLTAREN OPHTHA | 0.1% | SOLUTION | Resolved | 2017-11-30 | 2018-01-18 | 31276 |
VOLTAREN OPHTHA | 0.1% | SOLUTION | Resolved | 2018-03-26 | 2018-12-11 | 44015 |
VOLTAREN OPHTHA | 0.1% | SOLUTION | Resolved | 2018-03-26 | 2018-06-22 | 44018 |
VOLTAREN OPHTHA | 0.1% | SOLUTION | Avoided shortage | 2019-01-08 | 2019-04-29 | 71606 |
VOLTAREN OPHTHA | 0.1% | SOLUTION | Resolved | 2020-09-08 | 2020-10-08 | 123880 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
ONBREZ BREEZHALER | 75MCG | CAPSULE | Discontinued | 2022-06-29 | 2022-07-14 | 163678 |
ONBREZ BREEZHALER | 75MCG | CAPSULE | Discontinued | 2022-06-29 | 2022-07-14 | 163682 |
FORADIL DRY POWDER CAPSULES FOR INHALATION | 12MCG | CAPSULE | Discontinued | 2022-10-18 | 2023-01-25 | 172087 |
TASIGNA | 50MG | CAPSULE | Discontinued | 2023-10-19 | 2023-11-06 | 207564 |
ISOPTO CARPINE | 4% | LIQUID | Discontinued | 2022-05-11 | 2022-07-14 | 160361 |
TRANSDERM-NITRO 0.2 | 0.2MG | PATCH (EXTENDED RELEASE) | Discontinued | 2020-07-10 | 2020-12-21 | 119960 |
TRANSDERM-NITRO 0.4 | 0.4MG | PATCH (EXTENDED RELEASE) | Discontinued | 2020-07-10 | 2020-12-21 | 119964 |
TRANSDERM-NITRO 0.6 | 0.6MG | PATCH (EXTENDED RELEASE) | Discontinued | 2021-05-05 | 2022-01-17 | 138767 |
HYCAMTIN | 4MG | POWDER FOR SOLUTION | Discontinued | 2017-04-26 | 2019-06-11 | 8129 |
ILARIS | 150MG | POWDER FOR SOLUTION | Discontinued | 2019-09-11 | 2019-09-12 | 93588 |
EXTAVIA | 0.3MG | POWDER FOR SOLUTION | Discontinued | 2022-01-12 | 2022-02-11 | 152532 |
ARZERRA | 100MG | SOLUTION | Discontinued | 2019-03-11 | 2019-03-12 | 78215 |
ARZERRA | 1000MG | SOLUTION | Discontinued | 2019-03-11 | 2019-03-12 | 78219 |
LOPRESOR INJ 1.0MG/ML | 1MG | SOLUTION | Discontinued | 2019-04-05 | 2019-09-06 | 80607 |
VOLTAREN OPHTHA | 0.1% | SOLUTION | Discontinued | 2019-09-11 | 2019-11-07 | 93561 |
ZOFRAN | 2MG | SOLUTION | Discontinued | 2020-09-09 | 2021-05-05 | 123894 |
ZOFRAN | 2MG | SOLUTION | Discontinued | 2020-09-09 | 2021-09-23 | 123900 |
SANDOSTATIN | 200MCG | SOLUTION | Discontinued | 2022-02-08 | 2022-03-07 | 154429 |
ZOFRAN | 4MG | SOLUTION | Discontinued | 2022-06-29 | 2022-10-18 | 163685 |
LIORESAL INTRATHECAL 2MG/ML | 2MG | SOLUTION | Discontinued | 2023-08-10 | 2023-09-19 | 201573 |